Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APOBEC3A | P31941 | 1/20 | 0.39 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | HASPIN | Q8TF76 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | LIPC | P11150 | 1/20 | 0.34 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2923779 | 0.99 | APOBEC3A (0.40) | APOBEC3AAPOBEC3GHDAC3HDAC1MEN1 | |
| SCHEMBL23937675 | 0.76 | TUBB4A (0.39) | SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL7129548 | 0.75 | HDAC1 (0.41) | APOBEC3AAPOBEC3GHDAC3HDAC1MEN1 | |
| SCHEMBL7153095 | 0.74 | HDAC1 (0.41) | APOBEC3AAPOBEC3GHDAC3HDAC1MEN1 | |
| SCHEMBL20674246 | 0.70 | BRD4 (0.42) | SMN1; SMN2NPC1 | |
| Hydrochloric Acid SCHEMBL29140955 | 0.70 | NAAA (0.61) | APOBEC3AAPOBEC3GHDAC3HDAC1KMT2A | |
| SCHEMBL2928038 | 0.68 | KDM4E (0.47) | HDAC1MEN1KMT2ASMN1; SMN2MAPT | |
| SCHEMBL12876249 | 0.67 | L3MBTL1 (0.64) | APOBEC3AAPOBEC3GMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL2926629 | 0.65 | KDM4E (0.42) | HDAC1SMN1; SMN2MAPTRXFP1 | |
| SCHEMBL4403435 | 0.64 | NPC1 (0.74) | KMT2ASMN1; SMN2MAPTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6528650-B2 | Mixture containing coupler | L'OREAL S.A. (FR) | 2003-03-04 | — | — | US | claimed |
| US-20030019050-A9 | Novel cationic 4-hydroxyindoles, their use for the oxidation dyeing of keratinous fibers, dyeing compositions, and methods of dyeing | L'OREAL | 2003-01-30 | — | — | US | claimed |
| US-20020032937-A1 | Novel cationic 4-hydroxyindoles, their use for the oxidation dyeing of keratinous fibers, dyeing compositions, and methods of dyeing | L'OREAL | 2002-03-21 | — | — | US | claimed |
| US-6306181-B1 | FOR DYEING HUMAN HAIR | L'OREAL (FR) | 2001-10-23 | — | — | US | claimed |
| EP-0989128-B1 | 4-Hydroxyindoles kationic and their use for oxidation dyeing of keratinous fibres | OREAL (FR) | 2001-03-21 | — | — | EP | claimed |
| US-6528650-B2 | Mixture containing coupler | L'OREAL S.A. (FR) | 2003-03-04 | — | — | US | disclosed |
| US-20030019050-A9 | Novel cationic 4-hydroxyindoles, their use for the oxidation dyeing of keratinous fibers, dyeing compositions, and methods of dyeing | L'OREAL | 2003-01-30 | — | — | US | disclosed |
| US-20020032937-A1 | Novel cationic 4-hydroxyindoles, their use for the oxidation dyeing of keratinous fibers, dyeing compositions, and methods of dyeing | L'OREAL | 2002-03-21 | — | — | US | disclosed |
| US-6306181-B1 | FOR DYEING HUMAN HAIR | L'OREAL (FR) | 2001-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020032937-A1 | Novel cationic 4-hydroxyindoles, their use for the oxidation dyeing of keratinous fibers, dyeing compositions, and methods of dyeing | KRT18, KMO, H1-5 | APOBEC3A 3998/4885APOBEC3G 3985/4885HDAC3 526/4885 |
| US-20030019050-A9 | Novel cationic 4-hydroxyindoles, their use for the oxidation dyeing of keratinous fibers, dyeing compositions, and methods of dyeing | KRT18, KMO, H1-5 | APOBEC3A 3998/4885APOBEC3G 3985/4885HDAC3 526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.